Risks and Benefits of COVID-19 Vaccines
David Wohl, MD, of UNC Health – School of Medicine, Infectious Diseases, and Cameron Wolfe, MBBS, of Duke Health, Infectious Diseases, brief the media on the Johnson & Johnson COVID-19 vaccine pause on April 13, 2021. Dr Wohl notes that the system is working – ased on the recognition of 6 events out of almost 7 million doses, the quick response, and the movement to action. Dr Wolfe notes that current data support the reduction of hospitalization and death, underscoring the importance of vaccination. Dr Wohl agreed, noting that the benefits clearly outweigh the risks.